Vaccinating adolescents: a debate for parents, not pediatricians

DECRYPTION – Vaccination of 12-17 year olds is a matter of concern for families.

Why vaccinate adolescents if the vast majority do not develop serious forms of Covid-19? Do we have enough perspective on the long-term effects of these new RNA vaccines, especially in young people in full growth? These questions still animate many family meals.

In France, vaccination with the Pfizer product has been open to 12-17 year olds since June 15, and 52% of them have already received their first injection. By giving the green light at the end of July to the use of the Moderna vaccine (available to general practitioners) for this population, the High Authority for Health recalled that the priority was to“Obtain a high level of coverage in all age groups” in order to limit the risk of virus transmission. But this collective goal is not enough for some parents.

The risk-benefit balance

For pediatricians, however, the time has passed for procrastination. In a press release published on July 22, the National Professional Pediatric Council

This article is for subscribers only. You have 81% left to discover.

Pushing back the limits of science is also freedom.

Continue reading your article for € 1 for 2 months

Already subscribed? Log in


Leave a Reply

Your email address will not be published. Required fields are marked *